Business Today Biocon concludes Rs 4,150 crore QIP; SBI Mutual Fund among 39 investors
Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the acquisition of its shareholding in Biocon Biologics Ltd.